perfluorobutane has been researched along with Breast Cancer in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 13 (68.42) | 24.3611 |
| 2020's | 5 (26.32) | 2.80 |
| Authors | Studies |
|---|---|
| Li, JX; Li, XL; Xu, HX; Yu, SY | 1 |
| Berger, A; Brill, K; Forsberg, F; Lazar, M; Liu, JB; Machado, P; Nazarian, S; Needleman, L; Willis, AI | 1 |
| Haga, M; Hirai, T; Ito, T; Kichikawa, K; Kobayashi, T; Marugami, A; Marugami, N; Nakai, T; Nakamura, T; Takewa, M | 1 |
| Cui, L; Hao, Y; Lei, Y; Sun, Y; Zhao, H | 1 |
| Aono, T; Ito, T; Kagara, N; Kim, SJ; Miyake, T; Motomura, K; Naoi, Y; Noguchi, S; Shimazu, K; Shimoda, M; Shimomura, A; Uji, K | 1 |
| Kagara, N; Kim, SJ; Miyake, T; Naoi, Y; Noguchi, S; Shimazu, K; Shimoda, M; Tanei, T | 1 |
| Hirai, T; Ito, T; Miyamoto, Y; Moriyasu, F; Omoto, K; Takada, E | 1 |
| Akagi, Y; Furukawa, M; Iwakuma, N; Mishima, M; Takenaka, M; Toh, U | 1 |
| Fukuda, K; Kamio, M; Kato, K; Nakata, N; Nishioka, M; Nogi, H; Ohta, T; Takeyama, H; Toriumi, Y | 1 |
| Haga, M; Hayashi, A; Hirai, T; Kobayashi, T; Kozuka, Y; Nakai, T; Nakamura, T; Noro, A; Ogawa, T; Ogura, T | 1 |
| Abe, H; Einama, T; Kaga, T; Kanazawa, R; Kyuno, K; Lee Wee, K; Matsuzawa, F; Shibuya, K; Suzuki, T; Taketomi, A; Tamura, E | 1 |
| Harashima, H; Hozumi, Y; Kawano, M; Matsunaga, H; Mizunuma, H; Omoto, K; Omoto, Y; Shiozawa, M; Take, N; Takehara, M; Taniguchi, N | 1 |
| Goldberg, BB; Yang, WT | 1 |
| Fujisawa, T; Hirakata, T; Horikoshi, H; Iijima, M; Saitoh, Y; Takeuchi, K; Yanagita, Y | 1 |
| Hirai, T; Kobayashi, T; Nakajima, Y; Nakamura, T | 1 |
| Chen, B; Chen, Y; Cui, L; Ding, H; Fang, X; Ji, X; Lang, M; Li, H; Li, R; Liang, P; Liu, Z; Shen, H; Shi, J; Wang, H; Wang, J; Wang, Y; Wei, T; Wu, C; Wu, Y; Xu, W; Yan, Y; Yang, N; Yang, W; Yang, Y; Ye, X; Yu, J; Zhou, P | 1 |
| Forbrich, A; Hitt, M; Paproski, RJ; Zemp, R | 1 |
| Amioka, A; Arihiro, K; Emi, A; Kadoya, T; Kajitani, K; Masumoto, N; Matsuura, K; Okada, M; Shigematsu, H | 1 |
| Bzyl, J; Grouls, C; Kiessling, F; Lederle, W; Palmowski, M; Penzkofer, T; Pochon, S; Rix, A; Schneider, M; Siepmann, M; Tardy, I | 1 |
2 trial(s) available for perfluorobutane and Breast Cancer
| Article | Year |
|---|---|
Efficacy of sonazoid (perflubutane) for contrast-enhanced ultrasound in the differentiation of focal breast lesions: phase 3 multicenter clinical trial.
Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Diagnosis, Differential; Female; Ferric Compounds; Gadolinium DTPA; Humans; Iron; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Oxides; Sensitivity and Specificity; Ultrasonography, Mammary | 2014 |
The detection of pCR after PST by contrast-enhanced ultrasonography for breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Contrast Media; Female; Ferric Compounds; Humans; Iron; Magnetic Resonance Imaging; Mastectomy, Segmental; Middle Aged; Oxides; Predictive Value of Tests; Preoperative Care; ROC Curve; Sensitivity and Specificity; Ultrasonography, Doppler, Color; Ultrasonography, Mammary | 2013 |
17 other study(ies) available for perfluorobutane and Breast Cancer
| Article | Year |
|---|---|
Repeated ultrasound-guided percutaneous thermal ablation combined with systemic therapy achieves a stable condition in an end-stage patient with more than 10 liver metastases from breast cancer: The importance of sonazoid assisted contrast-enhanced ultras
Topics: Breast Neoplasms; Catheter Ablation; Female; Ferric Compounds; Humans; Iron; Liver Neoplasms; Oxides; Treatment Outcome; Ultrasonography, Interventional | 2022 |
Sentinel Lymph Node Identification in Post Neoadjuvant Chemotherapy Breast Cancer Patients Undergoing Surgical Excision Using Lymphosonography.
Topics: Breast Neoplasms; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphadenopathy; Lymphatic Metastasis; Neoadjuvant Therapy; Radioactive Tracers; Sentinel Lymph Node; Sentinel Lymph Node Biopsy | 2023 |
Evaluation of background parenchymal enhancement in breast contrast-enhanced ultrasound with Sonazoid
Topics: Adult; Aged; Breast; Breast Density; Breast Neoplasms; Contrast Media; Female; Ferric Compounds; Humans; Image Enhancement; Iron; Middle Aged; Oxides; Parenchymal Tissue; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Ultrasonography, Mammary; Young Adult | 2020 |
Percutaneous Sonazoid-enhanced ultrasonography combined with in vitro verification for detection and characterization of sentinel lymph nodes in early breast cancer.
Topics: Breast Neoplasms; Female; Ferric Compounds; Humans; Iron; Lymph Nodes; Oxides; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Ultrasonography | 2021 |
Identification of sentinel lymph nodes by contrast-enhanced ultrasonography with Sonazoid in patients with breast cancer: a feasibility study in three hospitals.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Contrast Media; Feasibility Studies; Female; Ferric Compounds; Humans; Image Enhancement; Iron; Lymphatic Metastasis; Middle Aged; Neoplasm Grading; Neoplasm Staging; Oxides; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Ultrasonography | 2017 |
Real-Time Visualization of Lymphatic Flow to Sentinel Lymph Nodes by Contrast-Enhanced Ultrasonography with Sonazoid in Patients with Breast Cancer.
Topics: Breast Neoplasms; Female; Ferric Compounds; Humans; Image Enhancement; Iron; Lymphatic Vessels; Middle Aged; Oxides; Sentinel Lymph Node; Ultrasonography | 2019 |
Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Contrast Media; Female; Ferric Compounds; Follow-Up Studies; Humans; Iron; Liver Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Oxides; Prognosis; Tomography, X-Ray Computed; Ultrasonography, Mammary | 2016 |
Optimization of Region of Interest Drawing for Quantitative Analysis: Differentiation Between Benign and Malignant Breast Lesions on Contrast-Enhanced Sonography.
Topics: Adult; Aged; Algorithms; Breast Neoplasms; Contrast Media; Diagnosis, Differential; Female; Ferric Compounds; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Iron; Male; Middle Aged; Observer Variation; Oxides; Pattern Recognition, Automated; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography, Mammary | 2015 |
Impact of parametric imaging on contrast-enhanced ultrasound of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma; Contrast Media; Female; Ferric Compounds; Humans; Iron; Magnetic Resonance Imaging; Middle Aged; Observer Variation; Oxides; Prospective Studies; Single-Blind Method; Tumor Burden; Ultrasonography, Mammary | 2016 |
Sonazoid Can Help Visualize the Intraductal Spread of Breast Cancer.
Topics: Adult; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Contrast Media; Female; Ferric Compounds; Humans; Iron; Magnetic Resonance Imaging; Mastectomy, Segmental; Oxides; Ultrasonography | 2016 |
Sentinel node detection method using contrast-enhanced ultrasonography with sonazoid in breast cancer: preliminary clinical study.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Lobular; Carcinoma, Medullary; Contrast Media; Female; Ferric Compounds; Follow-Up Studies; Humans; Iron; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Oxides; Pilot Projects; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Ultrasonography, Interventional | 2009 |
Microbubble contrast-enhanced ultrasound for sentinel lymph node detection: ready for prime time?
Topics: Breast Neoplasms; Contrast Media; Female; Ferric Compounds; Humans; Image Enhancement; Iron; Lymph Nodes; Lymphatic Metastasis; Microbubbles; Oxides; Phospholipids; Preoperative Period; Sentinel Lymph Node Biopsy; Sulfur Hexafluoride; Ultrasonography, Mammary | 2011 |
[Contrast-enhanced ultrasonography using by sonazoid (spread diagnosis)].
Topics: Breast Neoplasms; Contrast Media; Female; Ferric Compounds; Humans; Image Enhancement; Iron; Oxides; Ultrasonography | 2012 |
Head-to-head comparison of perfluorobutane contrast-enhanced US and multiparametric MRI for breast cancer: a prospective, multicenter study.
Topics: Breast Neoplasms; Contrast Media; Female; Humans; Magnetic Resonance Imaging; Multiparametric Magnetic Resonance Imaging; Prospective Studies; Sensitivity and Specificity; Ultrasonography, Mammary | 2023 |
RNA biomarker release with ultrasound and phase-change nanodroplets.
Topics: Analysis of Variance; Biomarkers, Tumor; Breast Neoplasms; Cell Death; Cells, Cultured; Drug Delivery Systems; Female; Fluorocarbons; Humans; MicroRNAs; Microscopy, Confocal; Nanoparticles; Polymerase Chain Reaction; RNA, Messenger; Ultrasonics | 2014 |
Evaluation of Malignancy Grade of Breast Cancer Using Perflubutane-Enhanced Ultrasonography.
Topics: Adult; Aged; Breast Neoplasms; Contrast Media; Female; Fluorocarbons; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Grading; Perfusion Imaging; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography, Mammary | 2016 |
Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38).
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Contrast Media; Disease Models, Animal; Female; Fluorocarbons; Humans; Immunohistochemistry; Mice; Mice, Nude; Microbubbles; Molecular Biology; Neovascularization, Pathologic; Nitrogen; Random Allocation; Reference Values; Sensitivity and Specificity; Transplantation, Heterologous; Ultrasonography, Doppler; Vascular Endothelial Growth Factor Receptor-2 | 2011 |